Old maids: Aging and its impact on microglia function

International Journal of Molecular Sciences

Volumn 18, Issue 4, 2017, Pages

  Koellhoffer, Edward C ^a   McCullough, Louise D ^a   Ritzel, Rodney M ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Dysregulation; Inflammation; Microglia; Senescence

Indexed keywords

COLONY STIMULATING FACTOR; REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; DOWN REGULATION; IMMUNOSURVEILLANCE; INFLAMMATION; LEARNING AND MEMORY TEST; LONG TERM POTENTIATION; MICROGLIA; MILD COGNITIVE IMPAIRMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTOSIS; PHENOTYPE; REVIEW; TRAUMATIC BRAIN INJURY; ANIMAL; CELL AGING; CENTRAL NERVOUS SYSTEM; HOMEOSTASIS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

AGING; ANIMALS; CELL AGING; CENTRAL NERVOUS SYSTEM; HOMEOSTASIS; HUMANS; MICROGLIA; REACTIVE OXYGEN SPECIES;

EID: 85017260010     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18040769     Document Type: Review

References (153)

1. He, W., Goodkind, D., Kowal, P.R. An Aging World: 2015, U.S. Census Bureau, Ed., U.S. Government Publishing Office: Washington, DC, USA, 2015, p. 165.
2. Eshkoor, S.A., Hamid, T.A., Mun, C.Y., Ng, C.K. Mild cognitive impairment and its management in older people. Clin. Interv. Aging 2015, 10, 687-693.
3. Ovbiagele, B., Goldstein, L.B., Higashida, R.T., Howard, V.J., Johnston, S.C., Khavjou, O.A., Lackland, D.T., Lichtman, J.H., Mohl, S., Sacco, R.L., et al. Forecasting the future of stroke in the United States: A policy statement from the American Heart Association and American Stroke Association. Stroke 2013, 44, 2361-2375.
4. Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature 2016, 539, 180-186.
5. Bouchard, J., Villeda, S.A. Aging and brain rejuvenation as systemic events. J. Neurochem. 2015, 132, 5-19.
6. Salvioli, S., Capri, M., Valensin, S., Tieri, P., Monti, D., Ottaviani, E., Franceschi, C. Inflamm-aging, cytokines and aging: State of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology. Curr. Pharm. Des. 2006, 12, 3161-3171.
7. De Martinis, M., Franceschi, C., Monti, D., Ginaldi, L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 2005, 579, 2035-2039.
8. Wake, H., Moorhouse, A.J., Miyamoto, A., Nabekura, J. Microglia: Actively surveying and shaping neuronal circuit structure and function. Trends Neurosci. 2013, 36, 209-217.
9. Elmore, M.R., Najafi, A.R., Koike, M.A., Dagher, N.N., Spangenberg, E.E., Rice, R.A., Kitazawa, M., Matusow, B., Nguyen, H., West, B.L., et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 2014, 82, 380-397.
10. Wong, W.T. Microglial aging in the healthy CNS: Phenotypes, drivers, and rejuvenation. Front. Cell. Neurosci. 2013, 7, 22.
11. Hefendehl, J.K., Neher, J.J., Suhs, R.B., Kohsaka, S., Skodras, A., Jucker, M. Homeostatic and injury-induced microglia behavior in the aging brain. Aging Cell 2014, 13, 60-69.
12. Streit, W.J., Braak, H., Xue, Q.S., Bechmann, I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol. 2009, 118, 475-485.
13. Streit, W.J., Sammons, N.W., Kuhns, A.J., Sparks, D.L. Dystrophic microglia in the aging human brain. Glia 2004, 45, 208-212.
14. Bisht, K., Sharma, K.P., Lecours, C., Sanchez, M.G., El Hajj, H., Milior, G., Olmos-Alonso, A., Gomez-Nicola, D., Luheshi, G., Vallieres, L., et al. Dark microglia: A new phenotype predominantly associated with pathological states. Glia 2016, 64, 826-839.
15. Nakanishi, H., Wu, Z. Microglia-aging: Roles of microglial lysosome-and mitochondria-derived reactive oxygen species in brain aging. Behav. Brain Res. 2009, 201, 1-7.
16. Mrak, R.E., Griffin, S.T., Graham, D.I. Aging-associated changes in human brain. J. Neuropathol. Exp. Neurol. 1997, 56, 1269-1275.
17. Gray, D.A., Woulfe, J. Lipofuscin and aging: A matter of toxic waste. Sci. Aging Knowl. Environ. 2005, 2005, re1.
18. Ahmed, Z., Sheng, H., Xu, Y.F., Lin, W.L., Innes, A.E., Gass, J., Yu, X., Wuertzer, C.A., Hou, H., Chiba, S., et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. Am. J. Pathol. 2010, 177, 311-324.
19. Ritzel, R.M., Patel, A.R., Pan, S., Crapser, J., Hammond, M., Jellison, E., McCullough, L.D. Age-and location-related changes in microglial function. Neurobiol. Aging 2015, 36, 2153-2163.
20. Oliveira, V.C., Carrara, R.C., Simoes, D.L., Saggioro, F.P., Carlotti, C.G., Jr., Covas, D.T., Neder, L. Sudan Black B treatment reduces autofluorescence and improves resolution of in situ hybridization specific fluorescent signals of brain sections. Histol. Histopathol. 2010, 25, 1017-1024.
21. Moussaud, S., Draheim, H.J. A new method to isolate microglia from adult mice and culture them for an extended period of time. J. Neurosci. Methods 2010, 187, 243-253.
22. Von Bernhardi, R., Tichauer, J., Eugenin-von Bernhardi, L. Proliferating culture of aged microglia for the study of neurodegenerative diseases. J. Neurosci. Methods 2011, 202, 65-69.
23. Caldeira, C., Oliveira, A.F., Cunha, C., Vaz, A.R., Falcao, A.S., Fernandes, A., Brites, D. Microglia change from a reactive to an age-like phenotype with the time in culture. Front. Cell. Neurosci. 2014, 8, 152.
24. Martinez, F.O., Gordon, S. The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep. 2014, 6, 13.
25. Ransohoff, R.M. A polarizing question: Do M1 and M2 microglia exist? Nat. Neurosci. 2016, 19, 987-991.
26. Lee, D.C., Ruiz, C.R., Lebson, L., Selenica, M.L., Rizer, J., Hunt, J.B., Jr., Rojiani, R., Reid, P., Kammath, S., Nash, K., et al. Aging enhances classical activation but mitigates alternative activation in the central nervous system. Neurobiol. Aging 2013, 34, 1610-1620.
27. Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., Kirkland, J.L. Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J. Clin. Investig. 2013, 123, 966-972.
28. Coppe, J.P., Patil, C.K., Rodier, F., Sun, Y., Munoz, D.P., Goldstein, J., Nelson, P.S., Desprez, P.Y., Campisi, J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008, 6, 2853-2868.
29. Brown, D.I., Griendling, K.K. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ. Res. 2015, 116, 531-549.
30. Kang, J., Park, E.J., Jou, I., Kim, J.H., Joe, E.H. Reactive oxygen species mediate Aβ(25-35)-induced activation of BV-2 microglia. Neuroreport 2001, 12, 1449-1452.
31. Qin, L., Liu, Y., Wang, T., Wei, S.J., Block, M.L., Wilson, B., Liu, B., Hong, J.S. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 2004, 279, 1415-1421.
32. Bordt, E.A., Polster, B.M. NADPH oxidase-and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: A bipartisan affair? Free Radic. Biol. Med. 2014, 76, 34-46.
33. Ansari, M.A., Scheff, S.W. NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic. Biol. Med. 2011, 51, 171-178.
34. Lull, M.E., Levesque, S., Surace, M.J., Block, M.L. Chronic apocynin treatment attenuates β amyloid plaque size and microglial number in hAPP(751)(SL) mice. PLoS ONE 2011, 6, e20153.
35. Han, B.H., Zhou, M.L., Johnson, A.W., Singh, I., Liao, F., Vellimana, A.K., Nelson, J.W., Milner, E., Cirrito, J.R., Basak, J., et al. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice. Proc. Natl. Acad. Sci. USA 2015, 112, E881-E890.
36. Qin, L., Liu, Y., Hong, J.S., Crews, F.T. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration. Glia 2013, 61, 855-868.
37. Zhang, B., Bailey, W.M., McVicar, A.L., Gensel, J.C. Age increases reactive oxygen species production in macrophages and potentiates oxidative damage after spinal cord injury. Neurobiol. Aging 2016, 47, 157-167.
38. Njie, E.G., Boelen, E., Stassen, F.R., Steinbusch, H.W., Borchelt, D.R., Streit, W.J. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol. Aging 2012, 33, 195.e1-195.e12.
39. Von Bernhardi, R., Eugenin-von Bernhardi, L., Eugenin, J. Microglial cell dysregulation in brain aging and neurodegeneration. Front. Aging Neurosci. 2015, 7, 124.
40. Wu, Z., Yu, J., Zhu, A., Nakanishi, H. Nutrients, Microglia Aging, and Brain Aging. Oxid. Med. Cell. Longev. 2016, 2016, 7498528.
41. Denieffe, S., Kelly, R.J., McDonald, C., Lyons, A., Lynch, M.A. Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells. Brain Behav. Immun. 2013, 34, 86-97.
42. Costello, D.A., Lyons, A., Denieffe, S., Browne, T.C., Cox, F.F., Lynch, M.A. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: A role for Toll-like receptor activation. J. Biol. Chem. 2011, 286, 34722-34732.
43. Ritzel, R.M., Crapser, J., Patel, A.R., Verma, R., Grenier, J.M., Chauhan, A., Jellison, E.R., McCullough, L.D. Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury. J. Immunol. (Baltimore, Md.: 1950) 2016, 196, 3318-3330.
44. Shrivastava, K., Gonzalez, P., Acarin, L. The immune inhibitory complex CD200/CD200R is developmentally regulated in the mouse brain. J. Comp. Neurol. 2012, 520, 2657-2675.
45. Wang, X.J., Zhang, S., Yan, Z.Q., Zhao, Y.X., Zhou, H.Y., Wang, Y., Lu, G.Q., Zhang, J.D. Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: Roles of aging, superoxide, NADPH oxidase, and p38 MAPK. Free Radic. Biol. Med. 2011, 50, 1094-1106.
46. Frank, M.G., Barrientos, R.M., Biedenkapp, J.C., Rudy, J.W., Watkins, L.R., Maier, S.F. mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol. Aging 2006, 27, 717-722.
47. Walker, D.G., Dalsing-Hernandez, J.E., Campbell, N.A., Lue, L.F. Decreased expression of CD200 and CD200 receptor in Alzheimer’s disease: A potential mechanism leading to chronic inflammation. Exp. Neurol. 2009, 215, 5-19.
48. Lyons, A., McQuillan, K., Deighan, B.F., O’Reilly, J.A., Downer, E.J., Murphy, A.C., Watson, M., Piazza, A., O’Connell, F., Griffin, R., et al. Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide. Brain Behav. Immun. 2009, 23, 1020-1027.
49. Cox, F.F., Carney, D., Miller, A.M., Lynch, M.A. CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Behav. Immun. 2012, 26, 789-796.
50. Lyons, A., Downer, E.J., Costello, D.A., Murphy, N., Lynch, M.A. Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia. J. Neuroinflamm. 2012, 9, 107.
51. Varnum, M.M., Kiyota, T., Ingraham, K.L., Ikezu, S., Ikezu, T. The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer’s disease. Neurobiol. Aging 2015, 36, 2995-3007.
52. Lyons, A., Minogue, A.M., Jones, R.S., Fitzpatrick, O., Noonan, J., Campbell, V.A., Lynch, M.A. Analysis of the Impact of CD200 on Phagocytosis. Mol. Neurobiol. 2016.
53. Zujovic, V., Benavides, J., Vige, X., Carter, C., Taupin, V. Fractalkine modulates TNF-α secretion and neurotoxicity induced by microglial activation. Glia 2000, 29, 305-315.
54. Lyons, A., Lynch, A.M., Downer, E.J., Hanley, R., O’Sullivan, J.B., Smith, A., Lynch, M.A. Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J. Neurochem. 2009, 110, 1547-1556.
55. Fenn, A.M., Smith, K.M., Lovett-Racke, A.E., Guerau-de-Arellano, M., Whitacre, C.C., Godbout, J.P. Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand. Neurobiol. Aging 2013, 34, 2748-2758.
56. Duan, R.S., Yang, X., Chen, Z.G., Lu, M.O., Morris, C., Winblad, B., Zhu, J. Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice. Neurochem. Res. 2008, 33, 1085-1089.
57. Cribbs, D.H., Berchtold, N.C., Perreau, V., Coleman, P.D., Rogers, J., Tenner, A.J., Cotman, C.W. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: A microarray study. J. Neuroinflamm. 2012, 9, 179.
58. Bachstetter, A.D., Morganti, J.M., Jernberg, J., Schlunk, A., Mitchell, S.H., Brewster, K.W., Hudson, C.E., Cole, M.J., Harrison, J.K., Bickford, P.C., et al. Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol. Aging 2011, 32, 2030-2044.
59. Wynne, A.M., Henry, C.J., Huang, Y., Cleland, A., Godbout, J.P. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav. Immun. 2010, 24, 1190-1201.
60. Wu, J., Bie, B., Yang, H., Xu, J.J., Brown, D.L., Naguib, M. Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. Neurobiol. Aging 2013, 34, 2843-2852.
61. Lee, S., Xu, G., Jay, T.R., Bhatta, S., Kim, K.W., Jung, S., Landreth, G.E., Ransohoff, R.M., Lamb, B.T. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway. J. Neurosci. 2014, 34, 12538-12546.
62. Lee, S., Varvel, N.H., Konerth, M.E., Xu, G., Cardona, A.E., Ransohoff, R.M., Lamb, B.T. CX3CR1 deficiency alters microglial activation and reduces β-amyloid deposition in two Alzheimer’s disease mouse models. Am. J. Pathol. 2010, 177, 2549-2562.
63. Cho, S.H., Sun, B., Zhou, Y., Kauppinen, T.M., Halabisky, B., Wes, P., Ransohoff, R.M., Gan, L. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J. Biol. Chem. 2011, 286, 32713-32722.
64. Nash, K.R., Lee, D.C., Hunt, J.B., Jr., Morganti, J.M., Selenica, M.L., Moran, P., Reid, P., Brownlow, M., Guang-Yu Yang, C., Savalia, M., et al. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy. Neurobiol. Aging 2013, 34, 1540-1548.
65. Orre, M., Kamphuis, W., Osborn, L.M., Jansen, A.H., Kooijman, L., Bossers, K., Hol, E.M. Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction. Neurobiol. Aging 2014, 35, 2746-2760.
66. Floden, A.M., Combs, C.K. Microglia demonstrate age-dependent interaction with amyloid-β fibrils. J. Alzheimer’s Dis. JAD 2011, 25, 279-293.
67. Lynch, A.M., Murphy, K.J., Deighan, B.F., O’Reilly, J.A., Gun’ko, Y.K., Cowley, T.R., Gonzalez-Reyes, R.E., Lynch, M.A. The impact of glial activation in the aging brain. Aging Dis. 2010, 1, 262-278.
68. Hendrickx, D.A., Schuurman, K.G., van Draanen, M., Hamann, J., Huitinga, I. Enhanced uptake of multiple sclerosis-derived myelin by THP-1 macrophages and primary human microglia. J. Neuroinflamm. 2014, 11, 64.
69. Gitik, M., Liraz-Zaltsman, S., Oldenborg, P.A., Reichert, F., Rotshenker, S. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes. J. Neuroinflamm. 2011, 8, 24.
70. Combs, C.K., Karlo, J.C., Kao, S.C., Landreth, G.E. β-Amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 2001, 21, 1179-1188.
71. Bliederhaeuser, C., Grozdanov, V., Speidel, A., Zondler, L., Ruf, W.P., Bayer, H., Kiechle, M., Feiler, M.S., Freischmidt, A., Brenner, D., et al. Age-dependent defects of α-synuclein oligomer uptake in microglia and monocytes. Acta. Neuropathol. 2016, 131, 379-391.
72. Tichauer, J.E., Flores, B., Soler, B., Eugenin-von Bernhardi, L., Ramirez, G., von Bernhardi, R. Age-dependent changes on TGFbeta1 Smad3 pathway modify the pattern of microglial cell activation. Brain Behav. Immun. 2014, 37, 187-196.
73. Chakrabarty, P., Li, A., Ceballos-Diaz, C., Eddy, J.A., Funk, C.C., Moore, B., DiNunno, N., Rosario, A.M., Cruz, P.E., Verbeeck, C., et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron 2015, 85, 519-533.
74. Guillot-Sestier, M.V., Doty, K.R., Gate, D., Rodriguez, J., Jr., Leung, B.P., Rezai-Zadeh, K., Town, T. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 2015, 85, 534-548.
75. Kan, M.J., Lee, J.E., Wilson, J.G., Everhart, A.L., Brown, C.M., Hoofnagle, A.N., Jansen, M., Vitek, M.P., Gunn, M.D., Colton, C.A. Arginine deprivation and immune suppression in a mouse model of Alzheimer’s disease. J. Neurosci. 2015, 35, 5969-5982.
76. Dagher, N.N., Najafi, A.R., Kayala, K.M., Elmore, M.R., White, T.E., Medeiros, R., West, B.L., Green, K.N. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J. Neuroinflamm. 2015, 12, 139.
77. Rice, R.A., Spangenberg, E.E., Yamate-Morgan, H., Lee, R.J., Arora, R.P., Hernandez, M.X., Tenner, A.J., West, B.L., Green, K.N. Elimination of Microglia Improves Functional Outcomes Following Extensive Neuronal Loss in the Hippocampus. J. Neurosci. 2015, 35, 9977-9989.
78. Feng, X., Jopson, T.D., Paladini, M.S., Liu, S., West, B.L., Gupta, N., Rosi, S. Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits. J. Neuroinflamm. 2016, 13, 215.
79. Acharya, M.M., Green, K.N., Allen, B.D., Najafi, A.R., Syage, A., Minasyan, H., Le, M.T., Kawashita, T., Giedzinski, E., Parihar, V.K., et al. Elimination of microglia improves cognitive function following cranial irradiation. Sci. Rep. 2016, 6, 31545.
80. Cunningham, C. Microglia and neurodegeneration: The role of systemic inflammation. Glia 2013, 61, 71-90.
81. Baruch, K., Deczkowska, A., David, E., Castellano, J.M., Miller, O., Kertser, A., Berkutzki, T., Barnett-Itzhaki, Z., Bezalel, D., Wyss-Coray, T., et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 2014, 346, 89-93.
82. Soto, I., Graham, L.C., Richter, H.J., Simeone, S.N., Radell, J.E., Grabowska, W., Funkhouser, W.K., Howell, M.C., Howell, G.R. APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction. PLoS Biol. 2015, 13, e1002279.
83. Montagne, A., Barnes, S.R., Sweeney, M.D., Halliday, M.R., Sagare, A.P., Zhao, Z., Toga, A.W., Jacobs, R.E., Liu, C.Y., Amezcua, L., et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015, 85, 296-302.
84. Grabert, K., Michoel, T., Karavolos, M.H., Clohisey, S., Baillie, J.K., Stevens, M.P., Freeman, T.C., Summers, K.M., McColl, B.W. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 2016, 19, 504-516.
85. Villeda, S.A., Luo, J., Mosher, K.I., Zou, B., Britschgi, M., Bieri, G., Stan, T.M., Fainberg, N., Ding, Z., Eggel, A., et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011, 477, 90-94.
86. Smith, L.K., He, Y., Park, J.S., Bieri, G., Snethlage, C.E., Lin, K., Gontier, G., Wabl, R., Plambeck, K.E., Udeochu, J., et al. beta2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat. Med. 2015, 21, 932-937.
87. Carabotti, M., Scirocco, A., Maselli, M.A., Severi, C. The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 2015, 28, 203-209.
88. Erny, D., Hrabe de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 2015, 18, 965-977.
89. Graham, L.C., Harder, J.M., Soto, I., de Vries, W.N., John, S.W., Howell, G.R. Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer’s disease. Sci. Rep. 2016, 6, 21568.
90. Kohman, R.A., Bhattacharya, T.K., Wojcik, E., Rhodes, J.S. Exercise reduces activation of microglia isolated from hippocampus and brain of aged mice. J. Neuroinflamm. 2013, 10, 114.
91. Loncarevic-Vasiljkovic, N., Pesic, V., Todorovic, S., Popic, J., Smiljanic, K., Milanovic, D., Ruzdijic, S., Kanazir, S. Caloric restriction suppresses microglial activation and prevents neuroapoptosis following cortical injury in rats. PLoS ONE 2012, 7, e37215.
92. D’Mello, C., Ronaghan, N., Zaheer, R., Dicay, M., Le, T., MacNaughton, W.K., Surrette, M.G., Swain, M.G. Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain. J. Neurosci. 2015, 35, 10821-10830.
93. Popa-Wagner, A., Buga, A.M., Tica, A.A., Albu, C.V. Perfusion deficits, inflammation and aging precipitate depressive behaviour. Biogerontology 2014, 15, 439-448.
94. Bickford, P.C., Flowers, A., Grimmig, B. Aging leads to altered microglial function that reduces brain resiliency increasing vulnerability to neurodegenerative diseases. Exp. Gerontol. 2017.
95. Blazer, D.G., Yaffe, K., Karlawish, J. Cognitive aging: A report from the Institute of Medicine. JAMA 2015, 313, 2121-2122.
96. Patterson, S.L. Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1beta, BDNF and synaptic plasticity. Neuropharmacology 2015, 96, 11-18.
97. Androsova, G., Krause, R., Winterer, G., Schneider, R. Biomarkers of postoperative delirium and cognitive dysfunction. Front. Aging Neurosci. 2015, 7, 112.
98. Gleason, L.J., Schmitt, E.M., Kosar, C.M., Tabloski, P., Saczynski, J.S., Robinson, T., Cooper, Z., Rogers, S.O., Jr., Jones, R.N., Marcantonio, E.R., et al. Effect of Delirium and Other Major Complications on Outcomes After Elective Surgery in Older Adults. JAMA Surg. 2015, 150, 1134-1140.
99. Inouye, S.K., Westendorp, R.G., Saczynski, J.S. Delirium in elderly people. Lancet 2014, 383, 911-922.
100. Vasunilashorn, S.M., Ngo, L., Inouye, S.K., Libermann, T.A., Jones, R.N., Alsop, D.C., Guess, J., Jastrzebski, S., McElhaney, J.E., Kuchel, G.A., et al. Cytokines and Postoperative Delirium in Older Patients Undergoing Major Elective Surgery. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2015, 70, 1289-1295.
101. Godbout, J.P., Chen, J., Abraham, J., Richwine, A.F., Berg, B.M., Kelley, K.W., Johnson, R.W. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2005, 19, 1329-1331.
102. Godbout, J.P., Moreau, M., Lestage, J., Chen, J., Sparkman, N.L., O’Connor, J., Castanon, N., Kelley, K.W., Dantzer, R., Johnson, R.W. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2008, 33, 2341-2351.
103. Simone, M.J., Tan, Z.S. The role of inflammation in the pathogenesis of delirium and dementia in older adults: A review. CNS Neurosci. Ther. 2011, 17, 506-513.
104. Fonken, L.K., Frank, M.G. The Alarmin HMGB1 Mediates Age-Induced Neuroinflammatory Priming. J. Neurosci. 2016, 36, 7946-7956.
105. Huang, Y., Henry, C.J., Dantzer, R., Johnson, R.W., Godbout, J.P. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol. Aging 2008, 29, 1744-1753.
106. Rosczyk, H.A., Sparkman, N.L., Johnson, R.W. Neuroinflammation and cognitive function in aged mice following minor surgery. Exp. Gerontol. 2008, 43, 840-846.
107. Peng, M., Zhang, C., Dong, Y., Zhang, Y., Nakazawa, H., Kaneki, M., Zheng, H., Shen, Y., Marcantonio, E.R., Xie, Z. Battery of behavioral tests in mice to study postoperative delirium. Sci. Rep. 2016, 6, 29874.
108. Ren, Q., Peng, M., Dong, Y., Zhang, Y., Chen, M., Yin, N., Marcantonio, E.R., Xie, Z. Surgery plus anesthesia induces loss of attention in mice. Front. Cell. Neurosci. 2015, 9, 346.
109. Buchanan, J.B., Sparkman, N.L., Chen, J., Johnson, R.W. Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice. Psychoneuroendocrinology 2008, 33, 755-765.
110. Dantzer, R., Capuron, L., Irwin, M.R., Miller, A.H., Ollat, H., Perry, V.H., Rousey, S., Yirmiya, R. Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology 2008, 33, 18-29.
111. Coronado, V.G., Thomas, K.E., Sattin, R.W., Johnson, R.L. The CDC traumatic brain injury surveillance system: Characteristics of persons aged 65 years and older hospitalized with a TBI. J. Head Trauma Rehabil. 2005, 20, 215-228.
112. Faul, M., Coronado, V. Epidemiology of traumatic brain injury. Handb. Clin. Neurol. 2015, 127, 3-13.
113. Mosenthal, A.C., Lavery, R.F., Addis, M., Kaul, S., Ross, S., Marburger, R., Deitch, E.A., Livingston, D.H. Isolated traumatic brain injury: Age is an independent predictor of mortality and early outcome. J. Trauma 2002, 52, 907-911.
114. Stocchetti, N., Paterno, R., Citerio, G., Beretta, L., Colombo, A. Traumatic brain injury in an aging population. J. Neurotrauma 2012, 29, 1119-1125.
115. Livingston, D.H., Lavery, R.F., Mosenthal, A.C., Knudson, M.M., Lee, S., Morabito, D., Manley, G.T., Nathens, A., Jurkovich, G., Hoyt, D.B., et al. Recovery at one year following isolated traumatic brain injury: A Western Trauma Association prospective multicenter trial. J. Trauma 2005, 59, 1298-1304.
116. Testa, J.A., Malec, J.F., Moessner, A.M., Brown, A.W. Outcome after traumatic brain injury: Effects of aging on recovery. Arch. Phys. Med. Rehabil. 2005, 86, 1815-1823.
117. Gardner, R.C., Burke, J.F., Nettiksimmons, J., Kaup, A., Barnes, D.E., Yaffe, K. Dementia risk after traumatic brain injury vs nonbrain trauma: The role of age and severity. JAMA Neurol. 2014, 71, 1490-1497.
118. Washington, P.M., Morffy, N., Parsadanian, M., Zapple, D.N., Burns, M.P. Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer’s disease mouse model. J. Neurotrauma 2014, 31, 125-134.
119. Chiu, C.C., Liao, Y.E., Yang, L.Y., Wang, J.Y., Tweedie, D., Karnati, H.K., Greig, N.H., Wang, J.Y. Neuroinflammation in animal models of traumatic brain injury. J. Neurosci. Methods 2016, 272, 38-49.
120. Johnson, V.E., Meaney, D.F., Cullen, D.K., Smith, D.H. Animal models of traumatic brain injury. Handb. Clin. Neurol. 2015, 127, 115-128.
121. Xiong, Y., Mahmood, A., Chopp, M. Animal models of traumatic brain injury. Nat. Rev. Neurosci. 2013, 14, 128-142.
122. Kumar, A., Stoica, B.A., Sabirzhanov, B., Burns, M.P., Faden, A.I., Loane, D.J. Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol. Aging 2013, 34, 1397-1411.
123. Fournier, A.E., Takizawa, B.T., Strittmatter, S.M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. Off. J. Soc. Neurosci. 2003, 23, 1416-1423.
124. Liu, G., Ni, J., Mao, L., Yan, M., Pang, T., Liao, H. Expression of Nogo receptor 1 in microglia during development and following traumatic brain injury. Brain Res. 2015, 1627, 41-51.
125. Sandu, R.E., Buga, A.M., Balseanu, A.T., Moldovan, M., Popa-Wagner, A. Twenty-four hours hypothermia has temporary efficacy in reducing brain infarction and inflammation in aged rats. Neurobiol. Aging 2016, 38, 127-140.
126. Sandu, R.E., Uzoni, A., Ciobanu, O., Moldovan, M., Anghel, A., Radu, E., Coogan, A.N., Popa-Wagner, A. Post-stroke gaseous hypothermia increases vascular density but not neurogenesis in the ischemic penumbra of aged rats. Restor. Neurol. Neurosci. 2016, 34, 401-414.
127. Buga, A.M., Di Napoli, M., Popa-Wagner, A. Preclinical models of stroke in aged animals with or without comorbidities: Role of neuroinflammation. Biogerontology 2013, 14, 651-662.
128. Crapser, J., Ritzel, R., Verma, R., Venna, V.R., Liu, F., Chauhan, A., Koellhoffer, E., Patel, A., Ricker, A., Maas, K., et al. Ischemic stroke induces gut permeability and enhances bacterial translocation leading to sepsis in aged mice. Aging 2016, 8, 1049-1063.
129. Sieber, M.W., Claus, R.A., Witte, O.W., Frahm, C. Attenuated inflammatory response in aged mice brains following stroke. PLoS ONE 2011, 6, e26288.
130. Shin, J.A., Jeong, S.I., Kim, M., Yoon, J.C., Kim, H.S., Park, E.M. Visceral adipose tissue inflammation is associated with age-related brain changes and ischemic brain damage in aged mice. Brain Behav. Immun. 2015, 50, 221-231.
131. Hu, X., Li, P., Guo, Y., Wang, H., Leak, R.K., Chen, S., Gao, Y., Chen, J. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012, 43, 3063-3070.
132. Suenaga, J., Hu, X., Pu, H., Shi, Y., Hassan, S.H., Xu, M., Leak, R.K., Stetler, R.A., Gao, Y., Chen, J. White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke. Exp. Neurol. 2015, 272, 109-119.
133. Moraga, A., Pradillo, J.M., Garcia-Culebras, A., Palma-Tortosa, S., Ballesteros, I., Hernandez-Jimenez, M., Moro, M.A., Lizasoain, I. Aging increases microglial proliferation, delays cell migration, and decreases cortical neurogenesis after focal cerebral ischemia. J. Neuroinflamm. 2015, 12, 87.
134. Salloway, S., Sperling, R., Fox, N.C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L.S., Porsteinsson, A.P., Ferris, S., et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N. Engl. J. Med. 2014, 370, 322-333.
135. Brody, M., Liu, E., Di, J., Lu, M., Margolin, R.A., Werth, J.L., Booth, K., Shadman, A., Brashear, H.R., Novak, G. A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer’s disease. J. Alzheimer’s Dis. JAD 2016, 54, 1509-1519.
136. Ivanoiu, A., Pariente, J., Booth, K., Lobello, K., Luscan, G., Hua, L., Lucas, P., Styren, S., Yang, L., Li, D., et al. Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies. Alzheimer’s Res. Ther. 2016, 8, 24.
137. Vandenberghe, R., Rinne, J.O., Boada, M., Katayama, S., Scheltens, P., Vellas, B., Tuchman, M., Gass, A., Fiebach, J.B., Hill, D., et al. Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials. Alzheimer’s Res. Ther. 2016, 8, 18.
138. Sevigny, J., Chiao, P., Bussiere, T., Weinreb, P.H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 2016, 537, 50-56.
139. Querfurth, H.W., La Ferla, F.M. Alzheimer’s disease. N. Engl. J. Med. 2010, 362, 329-344.
140. Ries, M., Sastre, M. Mechanisms of Abeta Clearance and Degradation by Glial Cells. Front. Aging Neurosci. 2016, 8, 160.
141. Rodriguez, J.J., Butt, A.M., Gardenal, E., Parpura, V., Verkhratsky, A. Complex and differential glial responses in Alzheimer’s disease and ageing. Curr. Alzheimer Res. 2016, 13, 343-358.
142. Udeochu, J.C., Shea, J.M., Villeda, S.A. Microglia communication: Parallels between aging and Alzheimer’s disease. Clin. Exp. Neuroimmunol. 2016, 7, 114-125.
143. Braak, H., Braak, E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 1997, 18, 351-357.
144. Peters, F., Collette, F., Degueldre, C., Sterpenich, V., Majerus, S., Salmon, E. The neural correlates of verbal short-term memory in Alzheimer’s disease: An fMRI study. Brain J. Neurol. 2009, 132, 1833-1846.
145. Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J., Golenbock, D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008, 9, 857-865.
146. Heneka, M.T., Kummer, M.P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.C., et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 2013, 493, 674-678.
147. Meda, L., Cassatella, M.A., Szendrei, G.I., Otvos, L., Jr., Baron, P., Villalba, M., Ferrari, D., Rossi, F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374, 647-650.
148. Zhao, W., Zhang, J., Davis, E.G., Rebeck, G.W. Aging reduces glial uptake and promotes extracellular accumulation of Abeta from a lentiviral vector. Front. Aging Neurosci. 2014, 6, 210.
149. Hickman, S.E., Allison, E.K., El Khoury, J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice. J. Neurosci. Off. J. Soc. Neurosci. 2008, 28, 8354-8360.
150. Middeldorp, J., Lehallier, B., Villeda, S.A., Miedema, S.S., Evans, E., Czirr, E., Zhang, H., Luo, J., Stan, T., Mosher, K.I., et al. Preclinical Assessment of Young Blood Plasma for Alzheimer Disease. JAMA Neurol. 2016, 73, 1325-1333.
151. Xiang, Y., Bu, X.L., Liu, Y.H., Zhu, C., Shen, L.L., Jiao, S.S., Zhu, X.Y., Giunta, B., Tan, J., Song, W.H., et al. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease. Acta Neuropathol. 2015, 130, 487-499.
152. Wang, Y., Ulland, T.K., Ulrich, J.D., Song, W., Tzaferis, J.A., Hole, J.T., Yuan, P., Mahan, T.E., Shi, Y., Gilfillan, S., et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 2016, 213, 667-675.
153. Gottfried, E., Kunz-Schughart, L.A., Weber, A., Rehli, M., Peuker, A., Muller, A., Kastenberger, M., Brockhoff, G., Andreesen, R., Kreutz, M. Expression of CD68 in non-myeloid cell types. Scand. J. Immunol. 2008, 67, 453-463.